This one page information piece challenging the myths around medication assisted treatment for opioid use disorder was created by the National Council on Behavioral Health and is directed at physicians and other health care providers. Continue reading
Resource Tag: Medication Assisted Treatment
Medication assisted treatment
Methandone
Buprenorphine
Naltrexone
Vivitrol
Opioid treatment program (OTP)
Office based opioid treatment (OBOT)
Drug Addiction Treatment Act (DATA) waiver
Helping Recovery Residences Adapt to Support People with Medication-Assisted Recovery
The National Alliance for Recovery Residences published this guide for operators of recovery housing on how to incorporated medication assisted treatment for opioid use disorder into their programs. Continue reading
MAT-Capable Recovery Residences: How State Policymakers Can Enhance and Expand Capacity to Adequately Support Medication Assisted Recovery
The National Alliance for Recovery Residences published this guide to supporting the use of medication assisted treatment (MAT) in recovery housing programs in 2019. Directed at state and local policy makers, the report describes the challenges of adding MAT to recovery residence programs and proposes strategies for expanding recovery housing overall and specifically housing programs that can support residents on MAT. Continue reading
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Highlights
This four page document presents the highlights from the 2019 National Academies report on medication assisted treatment for opioid use disorder.
Funding Source: National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Conclusions
This one page document summarizes the conclusions of the 2019 National Academies report on medications for opioid use disorder. Continue reading
Medication Assisted Treatment Guidelines for Opioid Use Disorders
This 2014 guideline from the Michigan Department of Community Health provides an overview of addiction and opioid use disorder with information specifically about medication assisted treatment. Continue reading
Guidelines for Medication for Addiction Treatment for Opioid Use Disorder within the Emergency Department
The state of Massachusetts passed legislation in 2018 requiring acute care hospitals to develop programs to initiate medication assisted treatment (MAT) for patients with opioid use disorder (OUD) seen in the emergency department. These guidelines, developed by the Massachusetts Hospital Association and state College of Emergency Physicians, offer clinical and operational recommendations for hospitals when implementing this state policy. Continue reading
Benzodiazepine Use and Medication-Assisted Treatment
This patient education publication describes the risks of taking benzodiazepine medications while also being treated for opioid use disorder with medication assisted treatment. Continue reading
Extended-Release Opioid Agonists and Antagonist Medications for Addiction Treatment (MAT) in Patients with Opioid Use Disorder: Effectiveness and Value
This 2018 report from the Institute for Clinical and Economic Review compared the evidence for effectiveness and value of new extended-release medications for opioid use disorder (two buprenorphine injections, one buprenorphine implant, and naltrexone injection). Continue reading
State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic: Final Report
This report provides financing strategies and workforce development strategies for state policy makers interested in expanding access to treatment for opioid use disorder, particularly medication assisted treatment. Continue reading